Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting.

Calado J, Loeffler J, Sakallioglu O, Gok F, Lhotta K, Barata J, Rueff J.

Kidney Int. 2006 Mar;69(5):852-5.

2.

Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.

Santer R, Calado J.

Clin J Am Soc Nephrol. 2010 Jan;5(1):133-41. doi: 10.2215/CJN.04010609. Epub 2009 Nov 5. Review.

3.

Effect of kidney disease on glucose handling (including genetic defects).

Calado J, Santer R, Rueff J.

Kidney Int Suppl. 2011 Mar;(120):S7-13. doi: 10.1038/ki.2010.510. Review.

PMID:
21358700
4.

SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes?

Tönjes A, Kovacs P.

Pharmacogenomics. 2013 May;14(7):825-33. doi: 10.2217/pgs.13.61. Review.

PMID:
23651029
5.

[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].

Pérez López G, González Albarrán O, Cano Megías M.

Nefrologia. 2010;30(6):618-25. doi: 10.3265/Nefrologia.pre2010.Sep.10494. Review. Spanish.

6.

Glucose control by the kidney: an emerging target in diabetes.

Marsenic O.

Am J Kidney Dis. 2009 May;53(5):875-83. doi: 10.1053/j.ajkd.2008.12.031. Epub 2009 Mar 26. Review.

PMID:
19324482
7.

[Sodium-glucose co-transporter-2 inhibitors: from the bark of apple trees and familial renal glycosuria to the treatment of type 2 diabetes mellitus].

Mauricio D.

Med Clin (Barc). 2013 Sep;141 Suppl 2:31-5. doi: 10.1016/S0025-7753(13)70061-7. Review. Spanish.

PMID:
24444522
8.

[Mineralocorticoid resistance: pseudohypoaldosteronism type 1].

Fernandes-Rosa FL, Antonini SR.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):373-81. Review. Portuguese.

9.

Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.

Abdul-Ghani MA, Norton L, Defronzo RA.

Endocr Rev. 2011 Aug;32(4):515-31. doi: 10.1210/er.2010-0029. Epub 2011 May 23. Review.

PMID:
21606218
10.

The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.

Jensen HK.

Dan Med Bull. 2002 Nov;49(4):318-45. Review.

PMID:
12553167
11.

Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.

Edelheit O, Hanukoglu I, Gizewska M, Kandemir N, Tenenbaum-Rakover Y, Yurdakök M, Zajaczek S, Hanukoglu A.

Clin Endocrinol (Oxf). 2005 May;62(5):547-53. Review.

PMID:
15853823
12.

Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes.

Davidson JA, Kuritzky L.

Postgrad Med. 2014 Oct;126(6):33-48. doi: 10.3810/pgm.2014.10.2819. Review.

PMID:
25414933

Supplemental Content

Support Center